The main benefit of using Doxil over traditional doxorubicin is its reduced toxicity. The liposomal coating helps protect healthy tissues from the harsh effects of chemotherapy, leading to fewer side effects such as cardiotoxicity and myelosuppression. Additionally, Doxil's prolonged circulation time allows for more effective targeting of cancer cells.
